$1.60
-0.01 (-0.62%)
Analyst Consensus
Buy
16
Analysts
High
Coverage
Price Target
Analyst Price Target
+1,983.1% upside
Low Target
$30.09
Average Target
$33.33
High Target
$42.13
Current Price
$1.60
Current
$1.60
$1.60
Target
$33.33
$33.33
$30.09
$33.33 avg
$42.13
Scenario Analysis
Bear Case
$30.09
1,780.6%
Low target
Base Case
$33.33
+1,983.1%
Avg target
Bull Case
$42.13
+2,533.1%
High target
Risk/Reward
1.4x
Balanced
Price in Context
52-Week High
$19.40
-91.8% from high
52-Week Low
$1.31
+22.1% from low
Target vs 52W High
$33.33
+71.8% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.5% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |